Advances in medical diagnosis, treatment, and care (AMDTC) book series, Journal Year: 2024, Volume and Issue: unknown, P. 235 - 264

Published: Aug. 28, 2024

Peptide vaccines offer promise in cancer immunotherapy, leveraging specificity, safety, and the potential for targeted immune responses against tumors. By incorporating multiple epitopes, they enhance recognition can be customized based on individual patient profiles. This chapter explores peptide vaccines, emphasizing adjuvants that efficacy while balancing safety. Traditional like alum oil-in-water emulsions promote cell activation, toll-like receptor agonists stimulate innate immunity. Strategies to improve include combining with other agents overcoming challenges low immunogenicity. Future research should refine adjuvant formulations explore combination therapies maximize effectiveness of cancer.

Language: Английский